CW August 2002
Volume 11Issue Number 8 August 2002 ISSN 10593802 Anti-Androgen Therapy for Prostate Cancer: Reduced Disease Progression, Preserved BMDIn localized or locally advanced prostate cancer, bicalutamide reduces disease progression as compared with placebo. Also, compared with an LHRH analog agonist, it maintains testosterone levels and lean muscle mass.
Go to Previous Page Go to Next Page Source & Additional Reading 2002 Annual Meeting of the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
